Aurobindo Pharma Ltd Announces Board Meeting to Consider Buyback of Equity Shares

Aurobindo Pharma Ltd has informed the BSE that a meeting of the Board of Directors is scheduled on April 6, 2026. The meeting will consider and approve a proposal for buyback of fully paid-up equity shares of the company. The buyback is in accordance with the applicable provisions under the Companies Act, 2013, the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018, and other applicable laws. The trading window for dealing in securities of the company was closed for all its designated persons, connected persons, and their immediate relatives with effect from April 01, 2026, and shall remain closed until forty-eight hours after the declaration of the audited financial results of the Company for the financial year ending on March 31, 2026. The trading window is also closed in respect of the aforementioned buyback proposal.